Ligand Share Price

Ligand Share Price

NASDAQ: LGND | Mid Cap | Healthcare
$298.77
+$5.29 (1.80%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • Similar Stocks
  • FAQs

Ligand Stock Performance

Open
$293.83
Prev. Close
$293.48
Circuit Range
N/A
Day Range
$293.83 - $301.50
Year Range
$176.10 - $325.89
Volume
21,783
Average Traded
$299.14

Ligand Share Price Today

As of 19 November 2026, Ligand Pharmaceuticals Incorporated's share price is $298.77. The stock opened at $293.83, compared to its previous close of $293.48. During today's trading session, Ligand Pharmaceuticals Incorporated's share price traded between $293.83 and $301.50, with an average price of $297.67. Over the past 52 weeks, the stock has recorded a high of $325.89 and a low of $176.10. In terms of performance, Ligand Pharmaceuticals Incorporated's share price has risen by 28.82% over the last six months and is up 47.40% on a year-on-year basis.

Ligand Share Price Chart

Line chart of the Ligand price trend over the selected period. The price rose overall, ranging from 292.95 to 301.95, ending at 298.77.
$293.83$301.50
L
Show Current Price
H

Ligand Stock Fundamentals & Key Indicators

Market Cap
$5.78B
PE Ratio (TTM)
114.20
Dividend Yield
0.00%
EPS (TTM)
$2.57
Revenue (TTM)
$268.09B
Return On Equity (TTM)
5.35%
Profit Margin
46.42%
Debt to Equity
1.17
Quarterly Earnings Growth YoY
-163.62%

Ligand Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$59.67$51.72$63.69$78.75
Net Profit$44.78-$13.35$48.51-$28.49
Net Profit Margin75.05%-25.81%76.17%-36.18%
Income ChangeN/A-129.81%463.37%-158.73%

Ligand Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$196.25$131.31$167.13$268.09
Net Profit-$33.36$52.15-$4.03$124.45
Net Profit Margin-17.00%39.72%-2.41%46.42%
Income ChangeN/A256.32%-107.73%3188.09%

Ligand Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets728.37610.22549.79499.07
Current Assets832.27331.56237.43263.6
Total Assets1560.64941.77787.22762.67
Non Current Liabilities505.9874.2269.5266.37
Current Liabilities37.4537.1116.7898.81
Total Liabilities543.43111.3486.3165.18
Shareholders' Equity1017.21830.44700.91597.49

Ligand Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating49.3697.0549.58137.85
Investing-377.32-143.66-11.68163.62
Financing428.2297.14-59.95-275.99

About Ligand

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Ligand Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$323.88
$298.62
-7.43%
Oct 2026
$310.84
$322.58
+3.13%
Sep 2026
$285.38
$312.78
+9.99%
Aug 2026
$287.36
$284.37
-1.10%
Jul 2026
$309.34
$287.54
-8.97%
Jun 2026
$227.40
$315.86
+36.19%
May 2026
$227.63
$231.93
+1.18%
Apr 2026
$204.59
$229.22
+14.70%
Mar 2026
$199.41
$199.84
+0.68%
Feb 2026
$197.65
$198.50
+3.31%
Jan 2026
$189.97
$192.14
+1.60%
Dec 2025
$199.78
$189.11
-6.70%

Ligand Share Price FAQs